L-lactate-driven PSMD14 lactylation and stabilization promote lactate production and ferroptosis resistance via ENO1 in intrahepatic cholangiocarcinoma
Cancer Letters · 2026-05 · 646 · 218394
DOI: 10.1016/j.canlet.2026.218394 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Letters, 2026-05. Verfasst von Dong Cai und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatobiliary Surgery, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China; Division of Biliary Surgery, D…. Hauptthemen laut MEDLINE: Phosphopyruvate Hydratase, Ferroptosis, Tumor Suppressor Proteins, DNA-Binding Proteins. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 54 Literaturangaben. Gefördert von: Natural Science Foundation Project of Chongqing.
Abstract (Originalsprache)
Targeting ferroptosis is a promising treatment strategy for intrahepatic cholangiocarcinoma (ICC) given the limited number of currently available therapeutic drugs. However, the heterogeneity of tumor cells and their resistance to ferroptosis pose difficulties in the implementation of this strategy. Here, we constructed a novel ferroptosis resistance score (FRS) to quantitatively assess the ferroptosis resistance status of ICC samples. Next, we found that glycolysis is closely associated with the FRS and verified that L-lactate drives ferroptosis resistance via PSMD14 in vitro and in vivo. Mechanistically, L-lactate promoted the K100 lactylation of PSMD14 to delay proteasome-mediated degradation. PSMD14 subsequently interacted with ENO1 to decrease ENO1 K63-linked ubiquitination and inhibited lysosome-mediated ENO1 degradation. Importantly, targeting PSMD14 inhibited L-lactate production and ferroptosis resistance through ENO1 and significantly increased the efficacy of anti-PD-1 treatment. Furthermore, PSMD14 and ENO1 were highly expressed in tumor tissues and closely associated with a poor ICC prognosis. Overall, our study reveals the importance of the L-lactate/PSMD14/ENO1 axis in regulating ferroptosis resistance in ICC, suggesting a novel therapeutic target and strategy for treating this disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hepatobiliary Surgery, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China; Division of Biliary Surgery, Department of General Surgery, West China Hospital, Sichuan University,…
- Department of Hepatobiliary Surgery, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.
- Key Laboratory of Animal Disease and Human Health of Sichuan Province, Sichuan Agricultural University, Chengdu, 611130, China; Department of Pathology & Institute of Clinical Pathology, West China Hospital, Sichuan Uni…
- Department of Pathology & Institute of Clinical Pathology, West China Hospital, Sichuan University, Chengdu, 610041, China.
- Department of Kidney Transplantation, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
- Department of Hepatobiliary Surgery, Affiliated Hospital of Panzhihua University, Panzhihua Hospital of Integrated Traditional Chinese and Western Medicine, Panzhihua City, Sichuan Province, China.
Förderung
- Natural Science Foundation Project of Chongqing
Zitieren
APA
Cai, D., Zhong, G. C., Zhao, Z., Chen, M., Tao, Q., Dai, X., Jia, D., Cheng, L., Wu, Z., Li, S., Gong, J., & Gong, J. (2026). L-lactate-driven PSMD14 lactylation and stabilization promote lactate production and ferroptosis resistance via ENO1 in intrahepatic cholangiocarcinoma. Cancer Letters, 646, 218394. https://doi.org/10.1016/j.canlet.2026.218394
Vancouver
Cai D, Zhong GC, Zhao Z, Chen M, Tao Q, Dai X, et al. L-lactate-driven PSMD14 lactylation and stabilization promote lactate production and ferroptosis resistance via ENO1 in intrahepatic cholangiocarcinoma. Cancer Letters. 2026;646:218394. doi:10.1016/j.canlet.2026.218394
BibTeX
@article{Cai2026,
author = {Cai, Dong and Zhong, Guo-Chao and Zhao, Zhibo and Chen, Menglin and Tao, Qing and Dai, Xin and Jia, Degong and Cheng, Lve and Wu, Zhenru and Li, Shengwei and Gong, Jianping and Gong, Junhua},
title = {L-lactate-driven PSMD14 lactylation and stabilization promote lactate production and ferroptosis resistance via ENO1 in intrahepatic cholangiocarcinoma},
journal = {Cancer Letters},
year = {2026},
volume = {646},
pages = {218394},
doi = {10.1016/j.canlet.2026.218394}
}
EUVIMED